Cornelia Weiss-Haljiti is an Expert Medical Writer and a biochemist by training with a PhD in endothelial cell biology. For 10 years, she worked as a scientist leading projects and laboratories in academia, biotech, and pharmaceutical industry. Cornelia developed expertise in the discovery and validation of targets, drugs, and biomarkers.
In 2012, Cornelia joined Boehringer Ingelheim Pharma GmbH & Co. KG. to become a Medical Writer. She wrote regulatory documents across all phases and therapeutic areas. She holds the EMWA foundation and advanced certificate. Over time she became particularly interested in plain language writing, graphics, and design. She was the design lead of a digital platform to share lay summaries of study results with the public. Currently she leads and represents Informed Consent activities by the Lay Language & New Media Team, a specialized medical writing team within Boehringer Ingelheim.

Cornelia Weiss Haljiti

Boehringer Ingelheim